APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. - Wikidata - wikimedia - TriplyDB

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

http://www.wikidata.org/entity/Q53201479

about

Inflammation and Alzheimer's disease Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers Genetic risk factors in Alzheimer's disease Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3.Clinical rationale of genetic testing in dementia Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.Interleukin-1 and the immunogenetics of Alzheimer disease.ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset.Human whole-genome shotgun sequencing.The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins.Genetics of behavioral aging: animal models and the human condition.Neuroinflammation in Alzheimer's disease and prion disease.Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain Is Alpha-1 Antichymotrypsin Gene Polymorphism a Risk Factor for Primary Intracerebral Hemorrhage? A Case-Control Study and Meta-Analysis.Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies.Interactions between APP secretases and inflammatory mediators.Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.Systemic and central immunity in Alzheimer's disease: therapeutic implications.Review: systemic inflammation and Alzheimer's disease.The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Microglia function in Alzheimer's disease.Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease.Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia.Familial and population-based studies of apolipoprotein E and Alzheimer's disease.Genetic epidemiology of Parkinson's disease.Allele frequencies of +874T --> A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients.Alpha-1 antichymotrypsin gene signal peptide a/t polymorphism and primary intracerebral hemorrhage.Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study.Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy.Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury.Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.Genetic association study between alpha 1-antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population.Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis.Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.

P2860

Q28138617-7279013E-2166-4CA0-96DF-66AFFADA817D Q28345218-E3C360F3-B14F-44EB-8DC1-A9FA83E61184 Q31129910-0A005310-F1D7-47F9-9CD3-781D12355D3D Q33588353-7626FC38-27B5-43C9-81E7-246C768D19A0 Q33653843-1060073D-8190-4FF9-884C-96FFF78C23CE Q33714955-F2BCBEAB-0DF9-49D6-AEFF-3E0C44CA2C5A Q33806912-E1ED6398-BED1-41D8-A922-78708D173637 Q33941294-BAE27811-3EF8-4391-A7FF-5ABB125B83BA Q34147672-997F0A9F-E498-4288-8A04-7F3B70B9690D Q34425997-DC378F02-09B3-4AB9-95F4-4CB2F0491197 Q34448263-41D0B530-3E4F-446E-816F-79333C5705EA Q34847773-512940D1-CA05-4F45-B591-6C10632C1A43 Q34963776-CFA3B685-86BA-4D14-AD34-345B31CC2779 Q35091381-60DBD84D-A7C1-42BA-85DD-05C065C3203F Q35367680-B98425A3-9F7B-4F92-ACA8-CAABE0C6D83C Q35773966-5C0A2009-ADE3-4B4F-9747-41448151E343 Q35903761-65704FFB-DD0E-4C0C-90F6-A5402628173C Q36307711-40049C4E-5B1F-4E2E-B8CB-E235D3897D95 Q36607337-685A88E8-C4B7-43F9-8368-62D1CC9D6B19 Q37195010-5115B792-F2A2-4E17-977E-E7379CBC20C3 Q37377671-2A12B6D5-47D4-43AE-979E-E4547E25B512 Q37954456-F49B7518-7858-4F4D-B1B7-3AA2D935F38C Q38050498-03BA42E8-FD5D-4817-BD40-3950ABE1BFF0 Q38559820-1F9BA199-9AA2-47E8-93F1-7C37B1B449B2 Q41014561-502D8025-253E-47CB-902D-B4A42DE38CE0 Q41307805-0FC28769-69EE-4C18-AF25-2BAB75A36E27 Q42474426-82A166BA-D9B7-4A41-A0C3-D9CEBEDAB234 Q43681481-A3F4DD3F-3D9A-49C9-8189-69B7F566D552 Q44195128-FD457E30-8A17-4850-81BE-A6FDC42B1A99 Q44684179-5CB94108-74E1-4195-ADCC-226B61374FFE Q46192805-B20D688A-793F-467E-B73F-042DE471F363 Q48421288-1311BF52-1849-4F87-80D5-9509DF36C28E Q49127463-8C0B4E23-3A93-4096-AB40-738AAD42AB30 Q50438138-5CAC56EA-DF1F-4757-9663-01745DF901C3 Q50661663-E5FB93F8-4F33-4522-A685-F226E51D410E Q51975871-83C71F9A-2E4C-4789-8AAF-582AB5FBA578 Q53095034-39512605-996C-441A-A44D-29F71A287088 Q53215692-F779506F-FD65-4E7F-A685-183FAD2B731A Q53215696-2ADD227E-3266-488E-9D98-4A4D6B8C8F9D Q53215966-30EB9B52-20C9-4FE3-80ED-12B5BD477D25

P2860

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

http://www.wikidata.org/entity/Q53201479

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh-hant

name

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@en

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@nl

type

label

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@en

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@nl

prefLabel

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@en

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@nl

P1433

Q53201479-8A64B2F2-7217-4C5A-AA80-3F8ACFA1FCFC

P1476

Q53201479-DD746FE6-7D2B-4967-AA78-9D7A590D559B

P2093

Q53201479-1A2E16FC-0D00-4451-8F04-7A9F701A3F58

Q53201479-1E74A72C-92E1-4F24-B54A-EC6E69E8AF94

Q53201479-B4BFFED9-4E46-48B2-864E-3C564720E1D7

Q53201479-F1A8AED7-CA87-45E0-8228-37D4E08204E5

P2860

Q53201479-568DB371-D973-44AC-B191-82EAAA023A7E

Q53201479-5B4E3A80-FD6F-4F69-A332-FA6FC0A47CEA

Q53201479-6D079E9A-B1A2-4651-BAB5-036D6DADA1ED

Q53201479-6FAED25B-7185-4706-BA45-812380E6758C

Q53201479-85A07A63-F521-4D07-A9CD-41320D3EEA29

Q53201479-BFF222F2-0F52-4312-B27F-2AE35C578A1A

Q53201479-EC622924-4F4C-4EF4-AF4F-899A44450A15

P2888

Q53201479-AC4331D9-28C5-48F5-8D10-DAB0BCEBE0BF

P304

Q53201479-BDD5BB77-A5ED-4330-9830-3CDC1212A223

P31

Q53201479-3B1BE295-2F47-42E7-BDD9-88B8C84F0607

P356

Q53201479-13CEE168-9351-4A5E-AAF9-F17222AD49AC

P407

Q53201479-DA7433AA-BF50-499F-A5BE-3C1B297EFE24

P433

Q53201479-EC07A253-6F02-4C99-9F81-9C7812990469

P478

Q53201479-1D8EF844-C938-456B-954D-5D9607661711

P577

Q53201479-FBF9D33E-A4D0-47DC-856C-D392F6161665

P6179

Q53201479-82D7A482-230B-408F-BB78-6731251A31C8

P698

Q53201479-472D2013-3651-4B80-9581-C68D366FA6C1

P356

P1433

Nature Genetics

P1476

APOE*4-associated Alzheimer's ...... antichymotrypsin polymorphism.

@en

P2093

DeKosky ST

http://www.w3.org/2001/XMLSchema#string

Ferrell RE

http://www.w3.org/2001/XMLSchema#string

Kamboh MI

http://www.w3.org/2001/XMLSchema#string

Sanghera DK

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.

Proteinase inhibitor alpha 1-antichymotrypsin has different expression in various forms of neuronal ceroid lipofuscinosis.

Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

P2888

P304

486-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG0895-486

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

1995-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009662325

http://www.w3.org/2001/XMLSchema#string

P698

7670501

http://www.w3.org/2001/XMLSchema#string